PLA Test Brings Nuance to the Diagnosis of Early-Stage Melanoma
BOSTON – Although skin biopsy remains the gold standard for diagnosing early-stage melanoma, advances in genetic expression profiling are helping dermatologists provide a nuanced approach to managing suspicious lesions. One such test, the Pigmented Lesional Assay (PLA) uses adhesive patches applied to lesions of concern at the bedside to extract RNA from the stratum corneum …
PLA Test Brings Nuance to the Diagnosis of Early-Stage Melanoma Read More »









